Browse studies
Find your next paid study
2 recruiting studies matching your filters
Phase 2
ZAnzalintinib Neoadjuvant EValuation in Thyroid Oncology (ZANEVO)
To look at the effectiveness of zanzalintinib, followed by surgery, in treating advanced thyroid cancer. The safety of this treatment will also be studied.
Neoadjuvant TreatmentThyroid Cancer
Estimated
~$10 – $6,250
M.D. Anderson Cancer CenterNCT06959511
Phase 2
The 'SWIVEL' Study (Switch Vs Effects Relief): Effectiveness of a Medication 'Switch' vs Guideline-Directed Interventions for Relieving Side Effects of Aromatase Inhibitors Among Breast Cancer Patients
Researchers have learned that about 50% of women do not finish the standard 5-year breast cancer treatment with an aromatase inhibitor. An aromatase inhibitor …
Breast CancerAdjuvant TreatmentEarly Stage Breast Cancer
Estimated
~$10 – $6,250
Dartmouth-Hitchcock Medical CenterNCT07071038